行情

EDAP

EDAP

Edap Tms
NASDAQ

实时行情|Nasdaq Last Sale

2.279
+0.139
+6.50%
交易中 15:56 04/08 EDT
开盘
2.150
昨收
2.140
最高
2.340
最低
2.150
成交量
7,357
成交额
--
52周最高
5.42
52周最低
1.460
市值
6,608.61万
市盈率(TTM)
40.34
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测EDAP价格均价为5.22,最高价位5.47,最低价为4.969。

EPS

EDAP 新闻

更多
  • 美联储会议纪要:经济前景面临“极大程度”不确定性
  • 新浪美股 · 1小时前
  • 经济复苏为时尚早 全球市场持续震荡 欧股收盘走低
  • 新浪财经综合 · 2小时前
  • 调查:四分之一的美国人因疫情封锁措施失业或减薪
  • 新浪美股 · 2小时前
  • 美国调查丨快递小哥不干了!
  • 央视 · 2小时前

所属板块

先进医疗设备和技术
+3.76%
医疗设备和用品
+4.72%

热门股票

代码
价格
涨跌幅

EDAP 简况

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.
展开

微牛提供Edap Tms SA (ADR)(NASDAQ-EDAP)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的EDAP股票新闻,以帮助您做出投资决策。